When Bydureon is given by injection into the upper thigh once a week, it binds to the GLP-1 receptor, stimulating insulin release from the beta cells of the pancreas whenever we eat
In PD patients there are reports of decreased CSF post-proline cleaving enzyme (Hagihara and Nagatsu, 1987), increased dipeptidyl-aminopeptidase II (Hagihara et al., 1987), normal dipeptidyl-aminopeptidase IV (Hagihara et al., 1987), and normal glutamic oxaloacetic transaminase (GOT) (Steen and Thomas, 1962
Insulin Sensitization: Its primary metabolic benefit is increasing skeletal muscle insulin sensitivity and promoting GLUT4 translocation, which drives glucose clearance from the blood
KPV is mostly mouse work
Minimal Lifestyle Disruption : Unlike restrictive diets or invasive surgery, GLP-1 therapy allows for gradual, sustainable weight loss without the need for drastic lifestyle changes
For those exploring alternative delivery methods, oral semaglutide drops and tirzepatide drops represent different absorption pathways that may produce different digestive effect profiles
